Technology and Patents Sample Clauses

Technology and Patents. 5.1 The technology shall mean the technology claimed in the Patents (the "Technology"). The Licensor is - to the best of Licensor's knowledge - the owner of the Patents. Licensor shall in any respect remain the full owner of the Patents. 5.2 The Licensor has sole control of the Patents, including sole control of maintenance etc. of the patents within the Patents. The Licensor in its sole discretion shall always be entitled to proceed with any submission or action, including the limitation of the scope of or the abandonment of any or all of the patent applications within the Patents, provided that the Licensor makes reasonable efforts to inform the Licensee as early as possible and to consider its comments, where suitable. 5.3 The Licensee may request that the Patens are extended to specific countries. Licensor shall to a reasonable extent seek to apply for such extension. The costs in connection with such extension of the Patents and maintenance thereof shall be borne by the Licensee. Any request for extension of the patents to a specific country may be given up until 24 months from the priority date of the Patents. 5.4 Nothing in this Commercial License Agreement shall be construed as a requirement that the Licensor file or prosecute any patent application or to maintain any patent. Before abandonment of any patent within the Patents, AAU must first give a 90 days’ notice to the Licensee of such decision. Within this period, the Licensee may decide to take over the ownership of such specific patent within the Patents by written notification to Licensor’s Technology Transfer Office. Such decision by Licensee to take over the ownership to the specific patent within the Patents shall be received by the Licensor no later than 90 days after receipt of notice from the Licensor of Licensor’s intent to abandon the specific patent within the Patents. In the event of more than one license-holder to the Technology, such license-holders will be offered the ownership to the patent within the Patents in joint ownership. Transfer of ownership to the specific patent within the Patent shall be free of compensation to Licensor, but subject to the condition that all costs relating to the protection and maintenance of the specific patent within Patents from the date of transfer and any transfer costs are borne by the Licensee(s).
AutoNDA by SimpleDocs
Technology and Patents. 8.1 AHPC and Wyeth-Ayerst shall promptly advise Syntex of any developments and/or improvements made by AHPC or Wyeth-Ayerst with regard to the Agreement Compound and/or the Covered Product (the “Sublicensee Technology”), particularly with regard to any developments and/or improvements made by AHPC or Wyeth-Ayerst with respect to pharmaceutical compositions and/or formulations of the Agreement Compound, including, without limitation, compositions and/or formulations in other that oral dosage form for use with regard to an intravenous solution of the Agreement Compound. 8.2 (a) AHPC and Wyeth-Ayerst agree to grant, and do hereby grant, to Syntex and exclusive, but for AHPC and Wyeth-Ayerst, royalty-free, fully paid-up license in the Territory under the Sublicensee Technology developed by AHPC or Wyeth-Ayerst during the term hereof, and any patent applications and patents pertaining thereto. 8.2 (b) AHPC and Wyeth-Ayerst agree to grant, and do hereby grant, to Syntex an exclusive, but for AHPC and Wyeth-Ayerst, royalty-free, fully paid-up license in all countries outside the Territory under the Sublicensee Technology, developed by AHPC or Wyeth-Ayerst during the term hereof, and any patent applications and patents pertaining thereto.
Technology and Patents. Section 5.1. Promptly after execution of this License Agreement, ACI and PRICE shall fully disclose and provide NGVSI with a complete written description of the Transferred Technology to the extent they have not already done so. Section 5.2. PRICE and NGVSI, at NGVSI's expense, shall be jointly responsible for applying for DOT certification of any Technology Products requiring such certification, and NGVSI shall keep both ACI and PRICE fully aware of the status of any such certification applications. (a) Promptly after the execution of this Technology Transfer Agreement by all parties, ACI shall reassign its rights in all Technology Patents to NGVSI thereby transferring to NGVSI primary control over the prosecution and maintenance of any such Technology Patents. PRICE consents to the aforementioned reassignment, ACI and PRICE shall continue to cooperate and assist in such prosecution and maintenance, including executing any such documents and taking such actions as NGVSI shall deem necessary in connection with the Technology Patents. PRICE consents to the aforementioned reassignment. (b) In the event NGVSI elects to discontinue prosecuting or maintaining any Technology Patents, NGVSI shall notify ACI of its intent to do so after which ACI may elect to assume full responsibility for the prosecution and/or maintenance of such Technology Patents following their reassignment from NGVSI to ACI. Section 5.4. NGVSI shall keep ACI and PRICE notified of its intentions to seek equivalent patent protection on any Transferred Technology in any foreign countries at NGVSI's sole expense.
Technology and Patents. Pre-dating the Joint Development Agreement: PMUSA and SWM each shall retain ownership of their respective patents and technology, expertise and know-how [******].
Technology and Patents 

Related to Technology and Patents

  • Inventions and Patents For purposes of this Agreement, “Inventions” includes, without limitation, information, inventions, contributions, improvements, ideas, or discoveries, whether protectable or not, and whether or not conceived or made during work hours. Executive agrees that all Inventions conceived or made by Executive during the period of employment with Employer belong to Employer, provided they grow out of Executive’s work with Employer or are related in some manner to the Business, including, without limitation, research and product development, and projected business of Employer or its affiliated companies. Accordingly, Executive will: a. Make adequate written records of such Inventions, which records will be Employer’s property; b. Assign to Employer, at its request, any rights Executive may have to such Inventions for the U.S. and all foreign countries; c. Waive and agree not to assert any moral rights Executive may have or acquire in any Inventions and agree to provide written waivers from time to time as requested by Employer; and d. Assist Employer (at Employer’s expense) in obtaining and maintaining patents or copyright registrations with respect to such Inventions. Executive understands and agrees that Employer or its designee will determine, in its sole and absolute discretion, whether an application for patent will be filed on any Invention that is the exclusive property of Employer, as set forth above, and whether such an application will be abandoned prior to issuance of a patent. Employer will pay to Executive, either during or after the term of this Agreement, the following amounts if Executive is sole inventor, or Executive’s proportionate share if Executive is joint inventor: $750 upon filing of the initial application for patent on such Invention; and $1,500 upon issuance of a patent resulting from such initial patent application, provided Executive is named as an inventor in the patent. Executive further agrees that Executive will promptly disclose in writing to Employer during the term of Executive’s employment and for one (1) year thereafter, all Inventions whether developed during the time of such employment or thereafter (whether or not Employer has rights in such Inventions) so that Executive’s rights and Employer’s rights in such Inventions can be determined. Except as set forth on the initialed Exhibit B (List of Inventions) to this Agreement, if any, Executive represents and warrants that Executive has no Inventions, software, writings or other works of authorship useful to Employer in the normal course of the Business, which were conceived, made or written prior to the date of this Agreement and which are excluded from the operation of this Agreement.

  • Patents and Patent Applications To the Company’s knowledge, all patents and patent applications owned by or licensed to the Company or under which the Company has rights have been duly and properly filed and maintained; to the knowledge of the Company, the parties prosecuting such applications have complied with their duty of candor and disclosure to the USPTO in connection with such applications; and the Company is not aware of any facts required to be disclosed to the USPTO that were not disclosed to the USPTO and which could reasonably be expected to preclude the grant of a patent in connection with any such application or could reasonably be expected to form the basis of a finding of invalidity with respect to any patents that have issued with respect to such applications.

  • INTELLECTUAL PROPERTY RIGHTS - INVENTION AND PATENT RIGHTS A. General 1. NASA has determined that 51 U.S.C. § 20135(b) does not apply to this Agreement. Therefore, title to inventions made (conceived or first actually reduced to practice) under this Agreement remain with the respective inventing party(ies). No invention or patent rights are exchanged or granted under this Agreement, except as provided herein.

  • Licensed Patents Immune Design, at its expense, shall have the first right to file, prosecute and maintain all Licensed Patents for which Immune Design has any exclusive rights under this Agreement using patent counsel reasonably approved by IDRI, including conducting any interferences, reexaminations, reissues, oppositions, or request for patent term extension relating thereto. Immune Design shall conduct such filing, prosecution and maintenance in good faith, taking into consideration IDRI’s retained rights hereunder, and consistent with reasonable business judgment, provide IDRI with all relevant or material documentation and proposed filing in the Territory so that IDRI may be concurrently and promptly informed of the continuing prosecution, and consult with IDRI with regards to Immune Design’s patent strategy with the Licensed Patents for which Immune Design has any exclusive rights under this Agreement. Licensed Patents in the name of IDRI shall remain in the name of IDRI. Immune Design shall use commercially reasonable efforts to ***, as applicable. To the extent such ***, Immune Design shall provide IDRI reasonable opportunity to review and comment on such prosecution efforts regarding such Licensed Patents in the Territory, and any IDRI comments will be reasonably considered in such prosecution efforts, and included to the extent affecting the IDRI Exclusive Field or IDRI Territory, as the case may be. If Immune Design determines in its sole discretion to abandon or not maintain any Licensed Patent for which Immune Design has any exclusive rights under this Agreement in the Territory, then Immune Design shall promptly provide IDRI with written notice of such determination at least sixty (60) days before any deadline for taking action to avoid abandonment and shall provide IDRI with the right, opportunity and reasonable assistance to prepare, file, prosecute and maintain such Licensed Patent in the applicable jurisdiction in IDRI’s sole discretion and at IDRI’s expense, provided that Immune Design shall provide such reasonable assistance at its own costs and expenses. If IDRI elects to prepare, file, prosecute and maintain such Licensed Patent in such jurisdiction for which Immune Design has any exclusive rights, then Immune Design’s license rights to such Licensed Patent in such country will become nonexclusive in such country under such Licensed Patent (and/or patent application). If IDRI desires Immune Design to file, in a particular jurisdiction, a Licensed Patent for which Immune Design has any exclusive rights under this Agreement that claims priority to another Licensed Patent for which Immune Design has any exclusive rights under this Agreement, IDRI shall provide written notice to Immune Design requesting that Immune Design file such patent application in such jurisdiction. If IDRI provides such written notice to Immune Design, Immune Design shall either (i) file and prosecute such patent application and maintain any patent issuing thereon in such jurisdiction and the Parties shall share the related costs and expenses (A) in countries *** on the basis of *** percent (***%) Immune Design: *** percent (***%) IDRI or (B) in countries within the IDRI Territory equally; or (ii) notify IDRI that Immune Design does not desire to file such patent application in such jurisdiction and provide IDRI with the opportunity to file and prosecute such patent application, provided that if IDRI files and prosecutes such patent application in such jurisdiction, then Immune Design’s license rights to such License Patent in such country will become nonexclusive in such country under such Licensed GLA Patent (and/or patent application). Immune Design shall be responsible for the costs and expenses incurred in connection with its own activities for filing, prosecuting and maintaining the Licensed Patents; IDRI shall be responsible for monitoring of such activities by IDRI.

  • Intellectual Property, Inventions and Patents Executive acknowledges that all discoveries, concepts, ideas, inventions, innovations, improvements, developments, methods, designs, analyses, drawings, reports, patent applications, copyrightable work and mask work (whether or not including any confidential information) and all registrations or applications related thereto, all other proprietary information and all similar or related information (whether or not patentable) which relate to Parent’s or any of its Subsidiaries’ actual or anticipated business, research and development or existing or future products or services and which are conceived, developed or made by Executive (whether alone or jointly with others) while employed by the Company and its Subsidiaries, whether before or after the date of this Agreement (“Work Product”), belong to Parent, the Company or such Subsidiary. Executive shall promptly disclose such Work Product to the Board and, at the Company’s expense, perform all actions reasonably requested by the Board (whether during or after the Employment Period) to establish and confirm such ownership (including, without limitation, assignments, consents, powers of attorney and other instruments).

  • Copyrights and Patents When the RECIPIENT creates any copyrightable materials or invents any patentable property under this Agreement, the RECIPIENT may copyright or patent the same but ECOLOGY retains a royalty free, nonexclusive, and irrevocable license to reproduce, publish, recover, or otherwise use the material(s) or property, and to authorize others to use the same for federal, state, or local government purposes.

  • Patent Rights The State and the U. S. Department of Transportation shall have the royalty free, nonexclusive and irrevocable right to use and to authorize others to use any patents developed by the Engineer under this contract.

  • ROYALTIES AND PATENTS The Contractor shall pay all royalties and license fees. The Contractor shall defend all suits or claims for infringement of any patent rights and shall save the State harmless from loss on account thereof, except that the State shall be responsible for all such loss when a particular design, process or the product of a particular manufacturer or manufacturers is specified, but if the Contractor has reason to believe that the design, process or product specified is an infringement of a patent, The Contractor shall be responsible for such loss unless he promptly gives such information to the Architect.

  • Patent The development of patentable inventions or discoveries is not the primary purpose of the research activities of the faculty. Employees have no obligation to seek patent protection for the results of scientific work nor to modify research to enhance patentability. 10.6.1 OC agrees that employees have the unqualified right to publish their inventions, improvements, designs or developments and, except as noted in section 10.6.3, OC waives, disclaims and abandons any interest in or claims to any invention, improvement, design or development made by an employee or employees and unless otherwise provided in this Article, any invention, improvement design or development, or any patent arising therefrom shall be the sole property of the inventor(s). 10.6.2 Where the activities are a part of work performed for which OC is not paying the employee from any source and no OC space or equipment is being used, the employee shall be entitled to any and all royalties from such patents. Employees shall have the right to make their own arrangements at their own expense to patent an invention, an improvement, a design or development and, subject to the obligations in the Article and except as noted in section 10.6.3, shall be entitled to all the proceeds therefrom.

  • Licensed Patent Rights The Licensee shall indemnify and hold the IC, its employees, students, fellows, agents, and consultants harmless from and against all liability, demands, damages, expenses, and losses, including but not limited to death, personal injury, illness, or property damage in connection with or arising out of:

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!